PerkinElmer Launches Vectra 3 System For Quantitative Pathology Imaging Research

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the launch of its Vectra® 3 automated, high-throughput quantitative pathology imaging system. This solution’s new seven color multiplexing and visualization capabilities are designed to enable pathologists and oncologists conducting research to gain a deeper level of understanding of disease mechanisms related to new cancer immunotherapy approaches.